Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
Journal of Medicinal Chemistry
|
April 15, 2020
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease
Minhee Kim, Inseon Hwang, Haushabhau S Pagire, et al.
Nature Communications
|
January 20, 2024
Discovery of a peripheral 5HT<sub>2A</sub> antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis
Haushabhau S Pagire, Suvarna H Pagire, Byung-Kwan Jeong, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy
Dong Gun Kim, Kyu-Seok Hwang, Se Hwan Ahn, et al.
Journal of Medicinal Chemistry
|
January 10, 2019
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases
Dahye Lee, Haushabhau S Pagire, Suvarna H Pagire, et al.
Journal of Medicinal Chemistry
|
February 28, 2019
Correction to Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases
Dahye Lee, Haushabhau S Pagire, Suvarna H Pagire, et al.
The New England Journal of Medicine
|
August 8, 2022
Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease
Niek Verweij, Mary E Haas, Jonas B Nielsen, et al.
Nature Communications
|
August 23, 2022
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes
Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
Journal of Medicinal Chemistry
|
April 15, 2020
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease
Minhee Kim, Inseon Hwang, Haushabhau S Pagire, et al.
Nature Communications
|
January 20, 2024
Discovery of a peripheral 5HT<sub>2A</sub> antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis
Haushabhau S Pagire, Suvarna H Pagire, Byung-Kwan Jeong, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy
Dong Gun Kim, Kyu-Seok Hwang, Se Hwan Ahn, et al.
Journal of Medicinal Chemistry
|
January 10, 2019
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases
Dahye Lee, Haushabhau S Pagire, Suvarna H Pagire, et al.
Journal of Medicinal Chemistry
|
February 28, 2019
Correction to Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases
Dahye Lee, Haushabhau S Pagire, Suvarna H Pagire, et al.
The New England Journal of Medicine
|
August 8, 2022
Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease
Niek Verweij, Mary E Haas, Jonas B Nielsen, et al.
Nature Communications
|
August 23, 2022
Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes
Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al.
Page
of 19